The $6 Billion Shot at Making New Antibiotics—Before the Old Ones Fail
Antimicrobials cost as much to develop as other drugs, but [...]
Opinion: Antibiotic-resistant superbugs are a ticking time bomb in global health care
The global health-care system faces a ticking time bomb. Deadly [...]
Improving data sharing to increase the efficiency of antibiotic R&D
Greater investment is needed in antibiotic R&D, and more must [...]
Fighting the dangerous increase of multi drug-resistant Microbes
In 1928, Alexander Fleming discovered penicillin, which would become the [...]
New partnership to tackle threat of superbugs
West Coast, USA-based Forge Therapeutics has inked a deal with [...]
Forge Therapeutics, Basilea Pharmaceutica partner on antibiotics
San Diego’s Forge Therapeutics has partnered with Basilea Pharmaceutica to [...]
Forge Therapeutics, Basilea Sign Deal to Pursue New Antibiotics
Forge Therapeutics, founded in 2015 with the goal of developing [...]
Forge Therapeutics Gets up to $11.1M to Advance “Superbug” Drugs
As strains of bacteria evolve to fight back against common [...]
Antibiotic companies seek success by learning from each others’ failures
San Diego's Forge Therapeutics will get information from another company’s [...]
Anti-flu drug exploits weakness in H3N2 strain
More than 65,000 Americans have been victims of influenza A [...]